Los Angeles Capital Management LLC Tango Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $22.3 Billion
- Q1 2025
A detailed history of Los Angeles Capital Management LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 129,110 shares of TNGX stock, worth $183,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
129,110
Previous 70,452
83.26%
Holding current value
$183,336
Previous $217,000
18.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNGX
# of Institutions
127Shares Held
90.9MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$23.9 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$15.2 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$15.1 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$7.86 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$5.68 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $125M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...